Leathanach 1 ó 17 torthaí
FIELD OF INVENTION
The field of the invention generally relates to systems and methods for treating inflammatory and proliferative diseases, and wounds, using a UCP and/or Fas antibody or other inhibitor, optionally with a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor,
BACKGROUND OF INVENTION
The field of the invention generally relates to systems and methods for treating inflammatory and proliferative diseases, and wounds, using a UCP and/or Fas antibody or other inhibitor, optionally with a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor,
FIELD OF THE INVENTION
The present invention relates to tumor grading, in particular tumor grading by analysis of blood volume maps obtained by e.g. perfusion imaging using contrast agents.
BACKGROUND OF THE INVENTION
It is often of interest to locate and characterize tumors in a non-invasive
FIELD OF THE INVENTION
This invention relates to the art of inhibiting Sarcoma 180 tumor growths in living tissue with materials arresting angiogenesis. Specifically the invention deals with glycoprotein materials produced extracellularly from a strain of Candida albicans which is effective to
BACKGROUND OF THE INVENTION
Field of the Invention
The present technology describes a new way of treating malignant solid tumors.
Related Art
Historically, cancer fighting has been about blocking, inhibiting or binding to specific molecular targets. It is either the classic chemotherapeutic approach
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to the fields of contrast agents for use in imaging and nanoparticles. In certain aspects, gold nanoparticles attached to glucose or a glucose derivative, such as 2-Deoxy-D-Glucose (2-DG), are provided. Such
TECHNICAL FIELD
The present invention relates to a composition for treating cancer stem cells, which contains a glucose uptake inhibitor and a calcium pump inhibitor.
BACKGROUND ART
Anticancer drugs, which have recently been actively developed and are actually used in anticancer therapy, are mostly
CROSS-REFERENCE
This application claims priority to U.S. provisional application No. 60/991,660, filed 30 Nov. 2007, 60/952,686, filed 30 Jul. 2007, 60/915,882, filed 3 May 2007 and 60/910,403, filed 5 Apr. 2007, each of which is incorporated herein by reference.
FIELD OF THE INVENTION
The invention
REFERENCE TO A SEQUENCE LISTING
This application includes a sequence listing in a text file entitled SEQLIS021305003800US.txt, created on Oct. 6, 2008, and containing 96794 bytes, a paper copy of which is appended hereto.
1. Field of Invention
The invention relates to methods of determining the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a diagnostic agent for glycometabolic function comprising a glucose derivative as an active ingredient. In particular, the present invention relates to a diagnostic agent which is useful for indicating the
BACKGROUND OF THE INVENTION
Ultrasensitive quantification of cancer biomarkers in complex samples is of great significance to clinical decision-making, and thus facilitates enabling early-stage diagnosis, monitoring cancer progression and evaluating therapeutic interventions. Currently available
FIELD OF THE INVENTION
The present invention relates to image processing units and optical sensor devices for obtaining biophysical, biochemical, physiological and vital sign information from an array of photodetectors or from video image data including stored video image data.
BACKGROUND OF THE
TECHNICAL FIELD
The present invention relates to a novel glucose derivative. The present invention also relates to a cell imaging method and imaging agent using the novel glucose derivative. The present invention further relates to a method for detecting and/or imaging cancer cells using the novel
TECHNICAL FIELD
The present invention relates to a novel glucose derivative. The present invention also relates to a cell imaging method and imaging agent using the novel glucose derivative. The present invention further relates to a method for detecting and/or imaging cancer cells using the novel
BACKGROUND
Cancer has overtaken cardiovascular diseases as the number one killer in America since 2008 and it was estimated that 565,650 Americans died of cancer in 2008 alone. Different theories have been proposed for the cause of cancer and numerous strategies have been formulated and explored for